New insights on mcr-1-harboring plasmids from human clinical Escherichia coli isolates

PLoS One. 2024 Feb 26;19(2):e0294820. doi: 10.1371/journal.pone.0294820. eCollection 2024.

Abstract

Mobile colistin resistance (mcr) genes were described recently in Gram-negative bacteria including carbapenem-resistant Enterobacterales. There are ten mcr genes described in different Gram-negative bacteria, however, Escherichia coli harboring mcr-1 gene is by far the most frequent combination. In Argentina, mcr-1 gene was characterized only on plasmids belonging to IncI2 group. The aim of this work was to get new insights of mcr-1-harboring plasmids from E. coli. Eight E. coli isolates from a larger collection of 192 clinical E. coli isolates carrying the mcr-1 gene were sequenced using next generation technologies. Three isolates belonged to ST131 high-risk clone, and five to single ST, ST38, ST46, ST226, ST224, and ST405. Eight diverse mcr-1-harboring plasmids were analyzed: IncI2 (1), IncX4 (3), IncHI2/2A (3) and a hybrid IncFIA/HI1A/HI1B (1) plasmid. Plasmids belonging to the IncI2 (n = 1) and IncX4 (n = 3) groups showed high similarity with previously described plasmids. Two IncHI2/HI2A plasmids, showed high identity between them, while the third, showed several differences including additional resistance genes like tet(A) and floR. One IncFIA/H1A/H1B hybrid plasmid was characterized, highly similar to pSRC27-H, a prototype plasmid lacking mcr genes. mcr-1.5 variant was found in four plasmids with three different Inc groups: IncI2, IncHI2/HI2A and the hybrid FIA/HI1A/HI1B plasmid. mcr-1.5 variant is almost exclusively described in our country and with a high frequency. In addition, six E. coli isolates carried three allelic variants codifying for CTX-M-type extended-spectrum-β-lactamases: blaCTX-M-2 (3), blaCTX-M-65 (2), and blaCTX-M-14 (1). It is the first description of mcr-1 harboring plasmids different to IncI2 group in our country. These results represents new insights about mcr-1 harboring plasmids recovered from E. coli human samples from Argentina, showing different plasmid backbones and resistance gene combinations.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Colistin / pharmacology
  • Drug Resistance, Bacterial / genetics
  • Escherichia coli Proteins* / genetics
  • Escherichia coli*
  • Humans
  • Microbial Sensitivity Tests
  • Plasmids / genetics

Substances

  • Colistin
  • Anti-Bacterial Agents
  • Escherichia coli Proteins

Grants and funding

This work was supported by the regular federal budget of the National Ministry of Health of Argentina; the regular federal budget of the Public Health Ontario Laboratory, Toronto, ON, Canada; and Préstamo BID-PICT-2021-I-A-0603 to D.F. from ANPCYT, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.